YANKCOM Partnership bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 845 shares of the medical equipment provider's stock, valued at approximately $441,000.
Several other hedge funds have also made changes to their positions in ISRG. Massachusetts Financial Services Co. MA purchased a new stake in shares of Intuitive Surgical during the third quarter worth approximately $558,807,000. International Assets Investment Management LLC raised its position in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock worth $535,788,000 after acquiring an additional 1,088,415 shares in the last quarter. FMR LLC lifted its holdings in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB boosted its position in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Finally, State Street Corp grew its stake in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock worth $7,393,673,000 after purchasing an additional 210,363 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.
NASDAQ:ISRG opened at $590.90 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm's 50 day moving average is $551.99 and its two-hundred day moving average is $512.04. The company has a market cap of $210.47 billion, a P/E ratio of 92.18, a P/E/G ratio of 5.51 and a beta of 1.39.
In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the business's stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 over the last three months. 0.80% of the stock is owned by insiders.
Several brokerages recently commented on ISRG. Piper Sandler reiterated an "overweight" rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. BTIG Research lifted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research report on Tuesday, November 26th. Jefferies Financial Group upped their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. Finally, Robert W. Baird upped their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a report on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $613.10.
Check Out Our Latest Analysis on Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.